Picture of Percheron Therapeutics logo

PER — Percheron Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Antisense Therapeutics Announces Long COVID-19 Strategic Collaboration With U.S. Experts

Feb 24 (Reuters) - Antisense Therapeutics Ltd  ANP.AX :
    * ANNOUNCES SIGNING OF DEAL & START OF COLLABORATION TO
STUDY
NEUROLOGICAL ASPECTS OF LONG COVID-19 WITH U.S. BASED
RESEARCHERS

Source text for Eikon:  ID:nASX5dQx2K 
Further company coverage:  ANP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Percheron Therapeutics

See all news